Diabetes-related conditions/complications

Linguistic validation of the Norfolk Quality of Life (QoL) questionnaire in diabetic neuropathy
Competitive analysis and burden of illness in diabetic peripheral neuropathy
Literature review of PROs and endpoints of pain in peripheral diabetic neuropathy
PRO assessment in diabetic peripheral neuropathy
Validation study of the modified version of the Brief Pain Inventory – Short Form (mBPI-SF), MOS-S and 3 single item questions in diabetic peripheral neuropathy
Gap analysis and strategic recommendation for PRO and market access studies in diabetic peripheral neuropathy
Consultancy on the validity of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale for use in painful diabetic neuropathy patients
Interview study to understand the experience of walking pain among patients with diabetic peripheral neuropathy
Analysis of diabetic neuropathy

Value messages and objection handlers for anti-vascular endothelial growth factor therapy (anti-VEGF) treatment in diabetic retinopathy and retinopathy of prematurity

Scientific communication on the prevalence and cost of severe hypoglycaemic events in Denmark
Slide deck on hypoglycaemia in diabetes
Study poster on Hypoglycaemia in Insulin Treated (HIT) patients
Manuscripts reporting the findings of the HIT Study on hypoglycaemia in diabetes
Manuscript reporting hypoglycaemia data for the HIT survey in the Netherlands
Three manuscripts for treatment of hypoglycaemia
Interactive slide deck presentation of hypoglycaemia study results
Abstract and manuscript reporting analyses from a hypoglycaemia study in the UK
Two manuscripts reporting specific country analyses from a hypoglycaemia study (Austrian and Finnish)
Manuscript reporting specific country analyses from a hypoglycaemia study (Denmark)
Scientific communication and presentation of data from the cross EU HIT study in hypoglycaemia

Rapid payer research to inform investment decisions in diabetic macular edema
Cost-effectiveness model to inform investment decisions in diabetic macular edema
Content validation of a visual function questionnaire in diabetic macular edema and retinal vein occlusion
FDA claim strategy and endpoint review for a visual function questionnaire in diabetic macular edema (DME) and retinal vein occlusion (RVO)
Review of PRO measures in diabetic macular edema
Interviews with patients with diabetes-induced edema in the USA

Diabetic foot ulcer support for FDA meetings
Psychometric validation of the Diabetic Foot Ulcer Scale (and Short Form) and the Short Form Health Survey (SF-36)
Cost effectiveness analysis model for Portugal on a treatment for bacterial diabetic foot infections
PRO strategy of a HRQoL claim for diabetic foot ulcers in vascular endothelial growth factor (VEGF)

Review of protocol on a phase II study of subjects with severe gastroparesis due to diabetes mellitus
Cognitive debriefing of a symptom measure of gastroparesis in diabetics and standalone validation study

Related categories